The ELGX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ELGX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ELGX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ELGX Detailed Price Forecast - CNN Money||View ELGX Detailed Summary - Google Finance|
|View ELGX Detailed Summary - Yahoo! Finance||View ELGX Stock Research & Analysis - Zacks.com|
|View ELGX Trends & Analysis - Trade-Ideas||View ELGX Major Holders - Barrons|
|View ELGX Call Transcripts - NASDAQ||View ELGX Breaking News & Analysis - Seeking Alpha|
|View ELGX Annual Report - CompanySpotlight.com||View ELGX OTC Short Report - OTCShortReport.com|
|View ELGX Fundamentals - TradeKing||View ELGX SEC Filings - Bar Chart|
|View Historical Prices for ELGX - The WSJ||View Performance/Total Return for ELGX - Morningstar|
|View the Analyst Estimates for ELGX - MarketWatch||View the Earnings History for ELGX - CNBC|
|View the ELGX Earnings - StockMarketWatch||View ELGX Buy or Sell Recommendations - MacroAxis|
|View the ELGX Bullish Patterns - American Bulls||View ELGX Short Pain Metrics - ShortPainBot.com|
|View ELGX Stock Mentions - StockTwits||View ELGX Stock Mentions - PennyStockTweets|
|View ELGX Stock Mentions - Twitter||View ELGX Investment Forum News - Investor Hub|
|View ELGX Stock Mentions - Yahoo! Message Board||View ELGX Stock Mentions - Seeking Alpha|
|View Insider Transactions for ELGX - SECform4.com||View Insider Transactions for ELGX - Insider Cow|
|View ELGX Major Holdings Summary - CNBC||View Insider Disclosure for ELGX - OTC Markets|
|View Insider Transactions for ELGX - Yahoo! Finance||View Institutional Holdings for ELGX - NASDAQ|
|View ELGX Stock Insight & Charts - FinViz.com||View ELGX Investment Charts - StockCharts.com|
|View ELGX Stock Overview & Charts - BarChart||View ELGX User Generated Charts - Trading View|
Endologix, Inc. to Announce Third Quarter 2018 Financial Results on November 1, 2018
Posted on Monday October 22, 2018
Endologix, Inc. (ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the third quarter of fiscal year 2018 after the market close on Thursday, November 1, 2018. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. This conference call will also be webcast and can be accessed from the “Investors” section of the Company’s website at www.endologix.com.
Consolidated Research: 2018 Summary Expectations for Barnes & Noble, Boot Barn, Endologix, Pilgrim's Pride, OraSure Technologies, and Genesco — Fundamental Analysis, Key Performance Indications
Posted on Thursday October 18, 2018
NEW YORK, Oct. 18, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
FDA Classifies Previous Endologix AFX Safety Notice as Class I Recall
Posted on Friday October 05, 2018
Endologix® Inc. (ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that it has received notice that the U.S. Food and Drug Administration (FDA) has classified a voluntary recall action that Endologix took in July of this year as a Class I recall. The July recall involved Endologix’s issuance of a Safety Notice to healthcare professionals (HCPs) using the AFX® Endovascular AAA System. The Safety Notice, dated 20 July 2018, provided updated information on comparative AFX Type III endoleak rates, patient-tailored surveillance recommendations, and recommendations for intervening through an AFX device or re-intervening on an AFX device.
The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares
Posted on Wednesday October 03, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 1) Boston Scientific Corporation (NYSE: BSX ) Eli Lilly ...